TriVascular, Inc. Receives U.S. Humanitarian Device Exemption Approval for the Ovation Abdominal Stent Graft System. First of its kind approval expands access to minimally invasive aortic repair
Ablynx Receives €5 Million For Alzheimer's Research
Ablynx [ABLX] today announced that it has earned a €5 million milestone payment following Boehringer Ingelheim's decision to initiate development with its lead Nanobody candidate that was selected in May 2010.
Carotid Stent Systems Market to Double by 2015
The world market for carotid stent systems, which was valued at $150 million in 2010, is expected to double by 2015, according to a new Medtech Report titled:
Covidien Receives FDA Premarket Approval for Pipeline Embolization Device
Covidien today announced that it received Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for the Pipeline Embolization Device.
Sanofi-Aventis Wins Control of Genzyme
Sanofi-Aventis SA, France’s biggest drug maker, has won control of Genzyme Corp. in an acquisition worth at least $20 billion.
FDA Advisory Committee Recommends Approval of Pipeline Embolization Device
Covidien announced today that the U.S. Food and Drug Administration (FDA) Neurological Devices Advisory Panel voted to recommend approval for Pipeline Embolization Device, intended for the endovascular treatment of large or giant wide-necked intracranial aneurysms.
Serge Tailler Named CEO of The Pharmaceutical Strategist
BRUSSELS (MEDTECH WIRE) The Pharmaceutical Strategist (TPS) announced today the appointment of Serge Tailler to the position of President and CEO of TPS Global.
Subscribe to:
Posts (Atom)